278 related articles for article (PubMed ID: 23955261)
21. A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.
Ramani B; Harris GM; Huang R; Seki T; Murphy GG; Costa Mdo C; Fischer S; Saunders TL; Xia G; McEachin RC; Paulson HL
Hum Mol Genet; 2015 Mar; 24(5):1211-24. PubMed ID: 25320121
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP
Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710
[TBL] [Abstract][Full Text] [Related]
23. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice.
Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS
Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949
[TBL] [Abstract][Full Text] [Related]
24. Mouse ataxin-3 functional knock-out model.
Switonski PM; Fiszer A; Kazmierska K; Kurpisz M; Krzyzosiak WJ; Figiel M
Neuromolecular Med; 2011 Mar; 13(1):54-65. PubMed ID: 20945165
[TBL] [Abstract][Full Text] [Related]
25. A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in Oligodendrocytes.
Haas E; Incebacak RD; Hentrich T; Huridou C; Schmidt T; Casadei N; Maringer Y; Bahl C; Zimmermann F; Mills JD; Aronica E; Riess O; Schulze-Hentrich JM; Hübener-Schmid J
Mol Neurobiol; 2022 Jan; 59(1):495-522. PubMed ID: 34716557
[TBL] [Abstract][Full Text] [Related]
26. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.
Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL
Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747
[TBL] [Abstract][Full Text] [Related]
27. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.
Maejima T; Oka S; Hashimotodani Y; Ohno-Shosaku T; Aiba A; Wu D; Waku K; Sugiura T; Kano M
J Neurosci; 2005 Jul; 25(29):6826-35. PubMed ID: 16033892
[TBL] [Abstract][Full Text] [Related]
28. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
McLoughlin HS; Moore LR; Chopra R; Komlo R; McKenzie M; Blumenstein KG; Zhao H; Kordasiewicz HB; Shakkottai VG; Paulson HL
Ann Neurol; 2018 Jul; 84(1):64-77. PubMed ID: 29908063
[TBL] [Abstract][Full Text] [Related]
29. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
[TBL] [Abstract][Full Text] [Related]
30. Global Knockdown of Retinoid-related Orphan Receptor α in Mature Purkinje Cells Reveals Aberrant Cerebellar Phenotypes of Spinocerebellar Ataxia.
Yasui H; Matsuzaki Y; Konno A; Hirai H
Neuroscience; 2021 May; 462():328-336. PubMed ID: 32278059
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
Toonen LJA; Overzier M; Evers MM; Leon LG; van der Zeeuw SAJ; Mei H; Kielbasa SM; Goeman JJ; Hettne KM; Magnusson OT; Poirel M; Seyer A; 't Hoen PAC; van Roon-Mom WMC
Mol Neurodegener; 2018 Jun; 13(1):31. PubMed ID: 29929540
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone rescue cerebellar degeneration in SCA3 transgenic mice.
Wu S; Liu K; Cheng W; Su S; Lin Y; Lin T; Cheng Y; Chang J; Wu Y; Liu C
Biochem Biophys Res Commun; 2020 Aug; 529(2):467-473. PubMed ID: 32703453
[TBL] [Abstract][Full Text] [Related]
33. Calcium dynamics and electrophysiological properties of cerebellar Purkinje cells in SCA1 transgenic mice.
Inoue T; Lin X; Kohlmeier KA; Orr HT; Zoghbi HY; Ross WN
J Neurophysiol; 2001 Apr; 85(4):1750-60. PubMed ID: 11287496
[TBL] [Abstract][Full Text] [Related]
34. N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation.
Hübener J; Vauti F; Funke C; Wolburg H; Ye Y; Schmidt T; Wolburg-Buchholz K; Schmitt I; Gardyan A; Driessen S; Arnold HH; Nguyen HP; Riess O
Brain; 2011 Jul; 134(Pt 7):1925-42. PubMed ID: 21653538
[TBL] [Abstract][Full Text] [Related]
35. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
36. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Colomer Gould VF; Goti D; Pearce D; Gonzalez GA; Gao H; Bermudez de Leon M; Jenkins NA; Copeland NG; Ross CA; Brown DR
Neurobiol Dis; 2007 Sep; 27(3):362-9. PubMed ID: 17632007
[TBL] [Abstract][Full Text] [Related]
37. Mature Purkinje cells require the retinoic acid-related orphan receptor-α (RORα) to maintain climbing fiber mono-innervation and other adult characteristics.
Chen XR; Heck N; Lohof AM; Rochefort C; Morel MP; Wehrlé R; Doulazmi M; Marty S; Cannaya V; Avci HX; Mariani J; Rondi-Reig L; Vodjdani G; Sherrard RM; Sotelo C; Dusart I
J Neurosci; 2013 May; 33(22):9546-62. PubMed ID: 23719821
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
Evert BO; Vogt IR; Vieira-Saecker AM; Ozimek L; de Vos RA; Brunt ER; Klockgether T; Wüllner U
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1006-18. PubMed ID: 14575237
[TBL] [Abstract][Full Text] [Related]
39. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
[TBL] [Abstract][Full Text] [Related]
40. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]